NO923331L - N-substituerte aminometandifosfonsyrer - Google Patents

N-substituerte aminometandifosfonsyrer

Info

Publication number
NO923331L
NO923331L NO92923331A NO923331A NO923331L NO 923331 L NO923331 L NO 923331L NO 92923331 A NO92923331 A NO 92923331A NO 923331 A NO923331 A NO 923331A NO 923331 L NO923331 L NO 923331L
Authority
NO
Norway
Prior art keywords
substituted
aminometandy
phosphonic acids
sulfinyl
thio
Prior art date
Application number
NO92923331A
Other languages
English (en)
Other versions
NO923331D0 (no
Inventor
Knut Alfred Jaeggi
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO923331D0 publication Critical patent/NO923331D0/no
Publication of NO923331L publication Critical patent/NO923331L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Dental Preparations (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Det er beskrevet N-substituerte aminometandifosfonsyrer med formel I. hvor Ri er en aromatisk rest, X er oksy, tio, sulfinyl, sulfonyl eller en kovalent binding, alkangir en toverdig alifatisk rest, Rer hydrogen eller en enverdig alifatisk rest, n er 1, eller, i tilfelle X er oksy, tio, sulfinyl eller sulfonyl, kan n også være 0, eller et salt derav.Disse forbindelsen har verdifulle farmasøytiske egenskaper og er effektive f.eks. ved behandling av i tilstander som kan forbindes med forstyrrelser av kalsium-metabolismen. De fremstilles ved en i og for seg kjent fremgangsmåte.
NO92923331A 1991-08-27 1992-08-26 N-substituerte aminometandifosfonsyrer NO923331L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91810682 1991-08-27

Publications (2)

Publication Number Publication Date
NO923331D0 NO923331D0 (no) 1992-08-26
NO923331L true NO923331L (no) 1993-03-01

Family

ID=8208873

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92923331A NO923331L (no) 1991-08-27 1992-08-26 N-substituerte aminometandifosfonsyrer

Country Status (19)

Country Link
US (1) US5281748A (no)
EP (1) EP0531253B1 (no)
JP (1) JPH05222074A (no)
KR (1) KR930004317A (no)
AT (1) ATE147396T1 (no)
AU (1) AU657983B2 (no)
CA (1) CA2076801A1 (no)
DE (1) DE69216514T2 (no)
DK (1) DK0531253T3 (no)
ES (1) ES2096061T3 (no)
FI (1) FI923797A (no)
GR (1) GR3022243T3 (no)
HU (1) HUT62303A (no)
IL (1) IL102959A (no)
MX (1) MX9204905A (no)
NO (1) NO923331L (no)
NZ (1) NZ244078A (no)
TW (1) TW207543B (no)
ZA (1) ZA926434B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
TW258729B (no) * 1992-06-22 1995-10-01 Ciba Geigy
DE4223940A1 (de) * 1992-07-21 1994-01-27 Boehringer Mannheim Gmbh Neue acyclische Amidingruppen-haltige Diphosphonsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
GB9300641D0 (en) * 1993-01-14 1993-03-03 Zeneca Ltd Process
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
IT1303672B1 (it) 1998-07-28 2001-02-23 Nicox Sa Sali nitrati di farmaci attivi nei disordini ossei

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2316396C3 (de) * 1973-04-02 1975-09-18 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen N(1,1-Di-phosphono-äthyl)acetamidin, seine Herste lung und Verwendung zur Steinverhütung
DE3208600A1 (de) * 1982-03-10 1983-09-22 Henkel KGaA, 4000 Düsseldorf Amidinodiphosphonsaeuren
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4963681A (en) * 1987-07-06 1990-10-16 Norwich Eaton Pharmaceuticals, Inc. Process for synthesis of aminomethylene phosphonoalkylphosphinates
PH26923A (en) * 1989-03-08 1992-12-03 Ciba Geigy N-substituted amino alkanediphosphonic acids
IE912115A1 (en) * 1990-06-25 1992-01-01 Takeda Chemical Industries Ltd Bisphosphonic acid derivatives, their production and use
US5043099A (en) * 1990-07-13 1991-08-27 Kreh Robert P Mono- and di-substituted (diphosphonoalkylamino methyl)-4-hydroxybenzenesulfonic acid
IE914417A1 (en) * 1990-12-19 1992-07-01 Takeda Chemical Industries Ltd Bisphosphonic acid derivatives, their production and use

Also Published As

Publication number Publication date
DK0531253T3 (da) 1997-01-27
US5281748A (en) 1994-01-25
IL102959A (en) 1998-01-04
HU9202754D0 (en) 1992-12-28
EP0531253A1 (en) 1993-03-10
NO923331D0 (no) 1992-08-26
IL102959A0 (en) 1993-01-31
DE69216514T2 (de) 1997-07-31
ZA926434B (en) 1993-04-28
JPH05222074A (ja) 1993-08-31
AU657983B2 (en) 1995-03-30
FI923797A (fi) 1993-02-28
HUT62303A (en) 1993-04-28
DE69216514D1 (de) 1997-02-20
ATE147396T1 (de) 1997-01-15
CA2076801A1 (en) 1993-02-28
FI923797A0 (fi) 1992-08-24
KR930004317A (ko) 1993-03-22
MX9204905A (es) 1993-04-01
ES2096061T3 (es) 1997-03-01
NZ244078A (en) 1994-12-22
GR3022243T3 (en) 1997-04-30
EP0531253B1 (en) 1997-01-08
TW207543B (no) 1993-06-11
AU2128892A (en) 1993-03-04

Similar Documents

Publication Publication Date Title
DK0496378T3 (da) Biphenylderivater, lægemidler indeholdende disse forbindelser og fremgangsmåder til deres fremstilling
DK350987D0 (da) Diphosphonsyrederivater og fremgangsmaade til fremstilling deraf samt laegemidler indholdende disse forbindelser
NO308736B1 (no) 1,2-difenylpyrrolderivater, farmasøytiske preparater inneholdende disse, og deres anvendelse
HU910930D0 (en) Process for the production of 2,8-dioxa-bicyclo/3.2.1/octane derivatives and medical preparations containing them
NO923331L (no) N-substituerte aminometandifosfonsyrer
DE3789436D1 (de) Heteroring-substituierte Diphosphonatverbindungen, Arzneimittel und Verfahren zur Behandlung von abnormalen Kalzium- und Phosphatmetabolismen.
CA2136820A1 (en) Thio-Substituted Nitrogen-Containing Heterocyclic Phosphonate Compounds for Treating Abnormal Calcium and Phosphate Metabolism
DK0557879T3 (da) 4-amino-2-ureido-pyrimidin-5-carboxylsyreamider, fremgangsmåde til deres fremstilling, lægemidler med indhold af disse forbindelser og deres anvendelse
BE1002830A5 (fr) Composition desinfectante et/ou de conservation et procede de desinfection et/ou de conservation d'aliments.
HU901348D0 (en) Process for preparation of n-substituted aminoalkane diphosphonic acids
HUT40799A (en) Process for preparing substituted amines
DE69329199D1 (de) Schwefel-enthaltende phosphonat-verbindungen zur behandlung von abnormalem calzium- und phosphat- metabolismus
EP0401684A3 (de) Verfahren zur Herstellung von Organosiloxanen
IL104229A0 (en) 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates,phosphonates and phosphinates,and pharmaceutical compositions containing them
NO911237L (no) Fremgangsmaate for fremstilling av hydroxymethyl-indolizidiner og kinolizidiner
DE69509268D1 (de) Lungentransplantat-Konservierungsmittelmischung und Verfahren zur Lebendkonservierung von Lungentransplantaten
PT87598A (pt) Processo para a preparacao de oxazolonas triciclicas e de composicoes farmaceuticas que as contem
DE3167045D1 (en) Nicotinic derivatives of glucosamine, process for their preparation and related pharmaceutical compositions
DK211983A (da) Fremgangsmaade til fremstilling af 3-(10,11-dihydro-5h-dibenzo (a,d)-cyclohepten-5-yliden)-n,n-dimethyl-1-propanamin-n-oxid-dihydrat
BR8501824A (pt) Processo para a preparacao de n-iodopropargil-clorometanos-sulfonamidas,composicoes microbicidas,processos para combater microorganismos,e para a preparacao de composicoes
MY110182A (en) Novel phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism